ARTICLE | Clinical News
Atrigel polymerizing gel data
February 28, 1994 8:00 AM UTC
ATRX will drop development of its plant-derived anti-microbial, sanguinarine, and instead will use doxycycline in its drug delivery gel.
A clarifying study in 180 patients presented to the FDA last week showed that sanguinarine was not statistically different from vehicle, but doxycycline did give statistically significant improvement in the depths of gum pockets compared to vehicle controls. ...